Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Income from Continuing Operations (2023 - 2026)

Camp4 Therapeutics' Income from Continuing Operations history spans 3 years, with the latest figure at 12066000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 9.13% to 12066000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 50381000.0, a 2.5% increase, with the full-year FY2025 number at 50573000.0, up 2.35% from a year prior.
  • Income from Continuing Operations hit 12066000.0 in Q4 2025 for Camp4 Therapeutics, up from 13228000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for CAMP hit a ceiling of 11696000.0 in Q3 2023 and a floor of 13484000.0 in Q3 2024.
  • Historically, Income from Continuing Operations has averaged 12674100.0 across 3 years, with a median of 12543500.0 in 2025.
  • Biggest five-year swings in Income from Continuing Operations: dropped 15.29% in 2024 and later increased 9.13% in 2025.
  • Tracing CAMP's Income from Continuing Operations over 3 years: stood at 12990000.0 in 2023, then decreased by 2.22% to 13279000.0 in 2024, then rose by 9.13% to 12066000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CAMP at 12066000.0 in Q4 2025, 13228000.0 in Q3 2025, and 12575000.0 in Q2 2025.